{"id":369560,"date":"2025-12-11T14:00:01","date_gmt":"2025-12-11T08:30:01","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=369560"},"modified":"2025-12-11T13:38:43","modified_gmt":"2025-12-11T08:08:43","slug":"shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","title":{"rendered":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion"},"content":{"rendered":"
\n

New Delhi | December 10th, 2025:<\/span> Shardul Amarchand Mangaldas & Co. (SAM) advised Biocon Limited (“BL”) and its subsidiary Biocon Biologics Limited (“BBL”) on their ~USD 1.2 billion integration, involving BL’s acquisition of minority shareholdings in BBL from Viatris, Serum Institute Lifesciences, Tata Capital Growth Fund II and True North.<\/p>\n

The Transaction Team was led by Raghubir Menon, Partner and Regional Practice Head — Mumbai, M&A and Private Equity, General Corporate; and Natashaa Shroff, Partner, along with Tarumoy Chaudhuri, Partner; Rounak Agarwal, Principal Associate; Kriti Saraswat, Senior Associate; Sohini Banerjee, Associate; Mihira Jaggi, Associate; and Anushya Ramakrishna, Associate.<\/p>\n

The Competition Team was led by Shweta Shroff Chopra, Partner, and Supritha Prodaturi, Partner, supported by Parinita Kare, Senior Associate; Vasudha Verma, Associate; Saii S., Associate; and Janhavi Jyoti S., Associate.<\/p>\n

The Capital Markets Team included Prashant Gupta, Partner — National Practice Head — Capital Markets; Ruth Chenchiah, Partner; and Debolina Mitra, Senior Associate.<\/p>\n

The Banking & Finance Team comprised Shubhangi Garg, Partner, and Ansh Jain, Associate.<\/p>\n

The Securities Team included Yogesh Chande, Partner, and Anushri Mandal, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.<\/p>\n","protected":false},"author":67011,"featured_media":369567,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[94686,94680,94681,94685,94683,46701,94684,85282,94682],"class_list":["post-369560","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-billion-dollar-pharma-deal","tag-biocon-acquisition","tag-biocon-biologics-integration","tag-ma-pharma-india","tag-serum-institute-lifesciences","tag-shardul-amarchand-mangaldas","tag-tata-capital-growth-fund-ii","tag-true-north","tag-viatris-stake-sale"],"yoast_head":"\nShardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times<\/title>\n<meta name=\"description\" content=\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\" \/>\n<meta property=\"og:description\" content=\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-11T08:30:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\",\"name\":\"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp\",\"datePublished\":\"2025-12-11T08:30:01+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp\",\"width\":886,\"height\":590,\"caption\":\"Biocon Biologics integration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times","description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","og_description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-11T08:30:01+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","name":"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","datePublished":"2025-12-11T08:30:01+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","width":886,"height":590,"caption":"Biocon Biologics integration"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":372923,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/01\/16\/shardul-amarchand-mangaldas-advises-biocon-qip-4150-crore\/","url_meta":{"origin":369560,"position":0},"title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its \u20b94,150 crore Qualified Institutions Placement","author":"Editor","date":"January 16, 2026","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Biocon Limited on its \u20b94,150 crore Qualified Institutions Placement to fund the integration of Biocon Biologics and related debt repayment.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Biocon Qualified Institutions Placement","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369249,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","url_meta":{"origin":369560,"position":1},"title":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap","author":"Editor","date":"December 9, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at \u20b92,250 crore. The deal marks a significant restructuring in India\u2019s biopharmaceutical sector.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Serum-Biocon Transaction","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":369560,"position":2},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369190,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/khaitan-viatris-biocon-biologics-stake-sale-815-million\/","url_meta":{"origin":369560,"position":3},"title":"Khaitan & Co advised Viatris on its proposed sale of stake in Biocon Biologics to Biocon for USD 815 million","author":"Editor","date":"December 9, 2025","format":false,"excerpt":"Khaitan & Co advised Viatris on the USD 815 million sale of its stake in Biocon Biologics to Biocon via cash payment and preferential share allotment.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Viatris Biocon Biologics stake sale","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":317745,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/03\/19\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-the-branded-formulations-business-of-biocon-biologics-limited-in-india\/","url_meta":{"origin":369560,"position":4},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"March 19, 2024","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":292287,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/05\/16\/shardul-amarchand-mangaldas-advises-macquarie-capital-in-its-acquisition-of-majority-stake-in-excel-telesonic-india-private-limited-cloudextel\/","url_meta":{"origin":369560,"position":5},"title":"Shardul Amarchand Mangaldas advises Macquarie Capital in its acquisition of majority stake in Excel Telesonic India Private Limited (CloudExtel)","author":"Bhumika Indulia","date":"May 16, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas & Co. advised Macquarie Capital, the corporate advisory, capital markets, and principal investment arm of Macquarie Group, in its acquisition of majority stake in Excel Telesonic India Private Limited (CloudExtel), a leading Network as a Service (NaaS) provider in India. Shardul Amarchand Mangaldas & Co. advised on\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"shardul amarchand mangaldas","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=369560"}],"version-history":[{"count":3,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369560\/revisions"}],"predecessor-version":[{"id":369569,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369560\/revisions\/369569"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/369567"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=369560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=369560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=369560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}